Market Cap 1.82B
Revenue (ttm) 285.50M
Net Income (ttm) 27.59M
EPS (ttm) N/A
PE Ratio 58.10
Forward PE 70.85
Profit Margin 9.66%
Debt to Equity Ratio -4.79
Volume 3,389,500
Avg Vol 3,992,122
Day's Range N/A - N/A
Shares Out 307.07M
Stochastic %K 88%
Beta 0.82
Analysts Strong Sell
Price Target $9.61

Company Profile

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of therapeutic products and services for endocrine and orphan lung diseases in the United States. It offers Afrezza Inhalation Powder, an inhaled insulin used to improve glycemic control in adults with diabetes; the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults; and Tyvaso DPI for the treatment of pulmonary arterial hypertension and pul...

Industry: Biotechnology
Sector: Healthcare
Phone: 818 661 5000
Address:
1 Casper Street, Danbury, United States
clan
clan Dec. 13 at 10:52 PM
$MNKD @DRFSR Mrs. Crane is trying to hide from me. She's wearing green...
0 · Reply
NatesNotes
NatesNotes Dec. 13 at 5:53 PM
Nope, nothin' to see here – move along folks... ;-) In all seriousness, the chart below really does tell us all we need to know about how Wall Street's perception of (and confidence regarding) the $MNKD story has fluctuated over the years... and, as you can see, Wall Street is clearly starting to come around again after taking a second look post-Sanofi (so place yer bets accordingly, eh? ;-) ). #knowwhatyouown #factsmatter
4 · Reply
Outcomes
Outcomes Dec. 13 at 5:23 PM
$MNKD India fans…🤣 https://www.yahoo.com/sports/articles/lionel-messi-india-tour-descends-085930918.html
1 · Reply
RockyRambo25
RockyRambo25 Dec. 13 at 5:01 PM
$MNKD Okay okay okay…we have CONFIRMED breakout above 5.81, no resistance in area just above. If Mike drops a PR next week or if MS initiates coverage we easily blow through $6…😉
1 · Reply
Affizle
Affizle Dec. 13 at 4:02 PM
$MNKD While the market is closed for the weekend, I just want to remind all of the true believers here that this stock is the master of share price head fakes. Just when you think it is about to take off, it drops faster than Bill Clinton's pants at Jeffry Epstein's Caribbean retreat or on Epstein's Lolita express or Esptein's NY brownstone. LOLZ!
1 · Reply
kevinmik
kevinmik Dec. 13 at 3:08 PM
$MNKD In responce to MinnieSteve3, I believe Mannkind would benefit acquiring Pulmatrix divested assets including Isperse Technology and 3 drug candidates in their pipeline. One of those drug in Pulmatrix pipeline is partnered with CIPLA, who has ex-U.S. rights and would have Mannkind and United partnered on another drug. Pulmatrix current marketcap is $16 million and the cost to acquire their divested assets could be about the same.
1 · Reply
Ron77077
Ron77077 Dec. 13 at 2:57 PM
$MNKD Fidelity Analyst Equity Summary Score Rating for MNKD raised to 9.0 For comparison’s sake, some comparable ratings are: GOOGL 9.1 MNKD 9.0 UTHR 8.7 NVDA 8.3 AAPL 7.5 DELL 7.0 NFLX 4.6 MSFT 3.5 The Equity Summary Score provides a consolidated view of the ratings from a number of independent research providers on Fidelity.com. Some stocks are not rated by all research providers. Since the model uses a number of ratings to arrive at an Equity Summary Score, only stocks that have four or more firms rating them have an Equity Summary Score. It uses the providers’ relative, historical, recommendation performance along with other factors to give you an aggregate, historical accuracy‐weighted indication of the independent research firms’ stock sentiment.
2 · Reply
clan
clan Dec. 13 at 2:25 PM
$MNKD $UTHR Unither currently has ~$3B Cash equivalents on hand and a market cap of $22.3B. [B=billion]. $IBB
1 · Reply
clan
clan Dec. 13 at 2:10 PM
$MNKD Over the last 3 to 4 weeks, investor's eyes 👀 are opening toward MNKD. The writing on the wall is becoming clearer for the coming years' record Revenues. #mannkindismakingabuzz
1 · Reply
clan
clan Dec. 13 at 1:44 PM
$MNKD $UTHR An announcement of what the 2nd collaboration will be would certainly cause a pop in MNKD. Could come any day. #fomo
2 · Reply
Latest News on MNKD
MannKind Corporation (MNKD) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 3:51 PM EST - 5 weeks ago

MannKind Corporation (MNKD) Q3 2025 Earnings Call Transcript


MannKind: Durable Cash Engine, Optional Catalysts Pending

Oct 15, 2025, 12:55 PM EDT - 2 months ago

MannKind: Durable Cash Engine, Optional Catalysts Pending


MannKind to Present at Upcoming Investor Conferences

Aug 27, 2025, 4:05 PM EDT - 3 months ago

MannKind to Present at Upcoming Investor Conferences


MannKind Corporation: A Post-Q2 Assessment

Aug 6, 2025, 4:44 PM EDT - 4 months ago

MannKind Corporation: A Post-Q2 Assessment


MannKind (MNKD) Q2 Revenue Rises 6%

Aug 6, 2025, 10:26 AM EDT - 4 months ago

MannKind (MNKD) Q2 Revenue Rises 6%


Top 3 Health Care Stocks That May Rocket Higher This Quarter

Jun 11, 2025, 7:01 AM EDT - 6 months ago

Top 3 Health Care Stocks That May Rocket Higher This Quarter


MannKind: Why I'm Still Bullish Despite Tyvaso DPI Competition

May 27, 2025, 12:02 AM EDT - 7 months ago

MannKind: Why I'm Still Bullish Despite Tyvaso DPI Competition


MannKind Corporation (MNKD) Q1 2025 Earnings Call Transcript

May 8, 2025, 11:34 AM EDT - 7 months ago

MannKind Corporation (MNKD) Q1 2025 Earnings Call Transcript


MannKind Corporation (MNKD) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 9:09 PM EST - 10 months ago

MannKind Corporation (MNKD) Q4 2024 Earnings Call Transcript


MoneyShow's Best Investment Ideas For 2025: Part 8

Feb 3, 2025, 9:20 AM EST - 11 months ago

MoneyShow's Best Investment Ideas For 2025: Part 8

DELL FNV MSTR SKE SKYE AMSC


MannKind Expands Executive Leadership Team

Jan 6, 2025, 4:30 PM EST - 1 year ago

MannKind Expands Executive Leadership Team


MannKind to Present at 2024 UBS Healthcare Conference

Nov 5, 2024, 4:15 PM EST - 1 year ago

MannKind to Present at 2024 UBS Healthcare Conference


clan
clan Dec. 13 at 10:52 PM
$MNKD @DRFSR Mrs. Crane is trying to hide from me. She's wearing green...
0 · Reply
NatesNotes
NatesNotes Dec. 13 at 5:53 PM
Nope, nothin' to see here – move along folks... ;-) In all seriousness, the chart below really does tell us all we need to know about how Wall Street's perception of (and confidence regarding) the $MNKD story has fluctuated over the years... and, as you can see, Wall Street is clearly starting to come around again after taking a second look post-Sanofi (so place yer bets accordingly, eh? ;-) ). #knowwhatyouown #factsmatter
4 · Reply
Outcomes
Outcomes Dec. 13 at 5:23 PM
$MNKD India fans…🤣 https://www.yahoo.com/sports/articles/lionel-messi-india-tour-descends-085930918.html
1 · Reply
RockyRambo25
RockyRambo25 Dec. 13 at 5:01 PM
$MNKD Okay okay okay…we have CONFIRMED breakout above 5.81, no resistance in area just above. If Mike drops a PR next week or if MS initiates coverage we easily blow through $6…😉
1 · Reply
Affizle
Affizle Dec. 13 at 4:02 PM
$MNKD While the market is closed for the weekend, I just want to remind all of the true believers here that this stock is the master of share price head fakes. Just when you think it is about to take off, it drops faster than Bill Clinton's pants at Jeffry Epstein's Caribbean retreat or on Epstein's Lolita express or Esptein's NY brownstone. LOLZ!
1 · Reply
kevinmik
kevinmik Dec. 13 at 3:08 PM
$MNKD In responce to MinnieSteve3, I believe Mannkind would benefit acquiring Pulmatrix divested assets including Isperse Technology and 3 drug candidates in their pipeline. One of those drug in Pulmatrix pipeline is partnered with CIPLA, who has ex-U.S. rights and would have Mannkind and United partnered on another drug. Pulmatrix current marketcap is $16 million and the cost to acquire their divested assets could be about the same.
1 · Reply
Ron77077
Ron77077 Dec. 13 at 2:57 PM
$MNKD Fidelity Analyst Equity Summary Score Rating for MNKD raised to 9.0 For comparison’s sake, some comparable ratings are: GOOGL 9.1 MNKD 9.0 UTHR 8.7 NVDA 8.3 AAPL 7.5 DELL 7.0 NFLX 4.6 MSFT 3.5 The Equity Summary Score provides a consolidated view of the ratings from a number of independent research providers on Fidelity.com. Some stocks are not rated by all research providers. Since the model uses a number of ratings to arrive at an Equity Summary Score, only stocks that have four or more firms rating them have an Equity Summary Score. It uses the providers’ relative, historical, recommendation performance along with other factors to give you an aggregate, historical accuracy‐weighted indication of the independent research firms’ stock sentiment.
2 · Reply
clan
clan Dec. 13 at 2:25 PM
$MNKD $UTHR Unither currently has ~$3B Cash equivalents on hand and a market cap of $22.3B. [B=billion]. $IBB
1 · Reply
clan
clan Dec. 13 at 2:10 PM
$MNKD Over the last 3 to 4 weeks, investor's eyes 👀 are opening toward MNKD. The writing on the wall is becoming clearer for the coming years' record Revenues. #mannkindismakingabuzz
1 · Reply
clan
clan Dec. 13 at 1:44 PM
$MNKD $UTHR An announcement of what the 2nd collaboration will be would certainly cause a pop in MNKD. Could come any day. #fomo
2 · Reply
MinnieSteve3
MinnieSteve3 Dec. 13 at 1:40 PM
$MNKD I'd like to see Mannkind buy the full rights to iSPERSE, as well as Pulmatrix' PUR3100 asset, the Phase 2/3 ready acute migraine drug. Any idea what these assets might cost Mannkind?
0 · Reply
clan
clan Dec. 13 at 12:01 PM
$MNKD $UTHR $SPY Along with RECORD Revenues expected to be set EVERY quarter in 2026, Approvals will be many during the next 8 months, supporting...
0 · Reply
JohnB72
JohnB72 Dec. 13 at 3:35 AM
$MNKD are we worth $1 yet?
1 · Reply
pierrules
pierrules Dec. 13 at 2:23 AM
$MNKD Very nice week here 💪👍😎 Have a nice weekend 😁
1 · Reply
Kuka
Kuka Dec. 13 at 12:52 AM
$MNKD gee....we were unable to close above 6 bucks.... I guess there really was strong resistance....who could have thunk that.
1 · Reply
addiction2money
addiction2money Dec. 12 at 11:53 PM
$MNKD should get word that Cipla is actively marketing Afrezza IN India…it’s approved but they haven’t let it go just yet. Any day…
0 · Reply
NatesNotes
NatesNotes Dec. 12 at 11:52 PM
Looks like it was another great week for folks who are long $MNKD and actually paying attention to the story as it continues to unfold, eh? Here's to more gains in the weeks, months, and years ahead! Cheers! #knowwhatyouown #factsmatter
0 · Reply
suck_on_this
suck_on_this Dec. 12 at 9:38 PM
$MNKD CEO selling another huge chunk of shares. Looks like his wife and kids are going to be getting some nice Xmas presents this year https://investors.mannkindcorp.com/sec-filings/sec-filing/144/0001950047-25-010237
5 · Reply
Dogcatfish
Dogcatfish Dec. 12 at 9:04 PM
$MNKD News next week?
2 · Reply
Pickin
Pickin Dec. 12 at 8:55 PM
$MNKD it’s nice to see the share price going up. $1.20 presplit…. It’s got a long way to go till I see $5 presplit. It could happen but will take time.
1 · Reply
Scorpio808
Scorpio808 Dec. 12 at 8:52 PM
$MNKD Maybe we will get a Monday Morning PR on the India Shipment??
1 · Reply
neil36
neil36 Dec. 12 at 8:49 PM
0 · Reply